Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 2
2014 1
2015 1
2016 2
2017 4
2018 7
2019 12
2020 23
2021 27
2022 19
2023 40
2024 15

Text availability

Article attribute

Article type

Publication date

Search Results

141 results

Results by year

Filters applied: . Clear all
Page 1
HER2-Low Breast Cancer: Pathological and Clinical Landscape.
Tarantino P, Hamilton E, Tolaney SM, Cortes J, Morganti S, Ferraro E, Marra A, Viale G, Trapani D, Cardoso F, Penault-Llorca F, Viale G, Andrè F, Curigliano G. Tarantino P, et al. Among authors: trapani d. J Clin Oncol. 2020 Jun 10;38(17):1951-1962. doi: 10.1200/JCO.19.02488. Epub 2020 Apr 24. J Clin Oncol. 2020. PMID: 32330069 Review. No abstract available.
Global challenges and policy solutions in breast cancer control.
Trapani D, Ginsburg O, Fadelu T, Lin NU, Hassett M, Ilbawi AM, Anderson BO, Curigliano G. Trapani D, et al. Cancer Treat Rev. 2022 Mar;104:102339. doi: 10.1016/j.ctrv.2022.102339. Epub 2022 Jan 19. Cancer Treat Rev. 2022. PMID: 35074727 Review.
Variant allele frequency: a decision-making tool in precision oncology?
Boscolo Bielo L, Trapani D, Repetto M, Crimini E, Valenza C, Belli C, Criscitiello C, Marra A, Subbiah V, Curigliano G. Boscolo Bielo L, et al. Among authors: trapani d. Trends Cancer. 2023 Dec;9(12):1058-1068. doi: 10.1016/j.trecan.2023.08.011. Epub 2023 Sep 12. Trends Cancer. 2023. PMID: 37704501 Review.
Cancer in Transgender and Gender-Diverse Persons: A Review.
Leone AG, Trapani D, Schabath MB, Safer JD, Scout NFN, Lambertini M, Berardi R, Marsoni S, Perrone F, Cinieri S, Miceli R, Morano F, Pietrantonio F. Leone AG, et al. Among authors: trapani d. JAMA Oncol. 2023 Apr 1;9(4):556-563. doi: 10.1001/jamaoncol.2022.7173. JAMA Oncol. 2023. PMID: 36757703 Review.
Evolution of low HER2 expression between early and advanced-stage breast cancer.
Tarantino P, Gandini S, Nicolò E, Trillo P, Giugliano F, Zagami P, Vivanet G, Bellerba F, Trapani D, Marra A, Esposito A, Criscitiello C, Viale G, Curigliano G. Tarantino P, et al. Among authors: trapani d. Eur J Cancer. 2022 Mar;163:35-43. doi: 10.1016/j.ejca.2021.12.022. Epub 2022 Jan 13. Eur J Cancer. 2022. PMID: 35032815
Common Sense Oncology: outcomes that matter.
Booth CM, Sengar M, Goodman A, Wilson B, Aggarwal A, Berry S, Collingridge D, Denburg A, Eisenhauer EA, Ginsburg O, Goldstein D, Gunasekera S, Hammad N, Honda K, Jackson C, Karikios D, Knopf K, Koven R, Marini BL, Maskens D, Moraes FY, Mohyuddin GR, Poudyal BS, Pramesh CS, Roitberg F, Rubagumya F, Schott S, Sirohi B, Soto-Perez-de-Celis E, Sullivan R, Tannock IF, Trapani D, Tregear M, van der Graaf W, Vanderpuye V, Gyawali B. Booth CM, et al. Among authors: trapani d. Lancet Oncol. 2023 Aug;24(8):833-835. doi: 10.1016/S1470-2045(23)00319-4. Epub 2023 Jul 16. Lancet Oncol. 2023. PMID: 37467768 No abstract available.
The immunogram of inflammatory breast cancer.
Valenza C, Trapani D, Fusco N, Wang X, Cristofanilli M, Ueno NT, Curigliano G. Valenza C, et al. Among authors: trapani d. Cancer Treat Rev. 2023 Sep;119:102598. doi: 10.1016/j.ctrv.2023.102598. Epub 2023 Jul 8. Cancer Treat Rev. 2023. PMID: 37437342 Review.
Emerging Targeted Therapies for Early Breast Cancer.
Schlam I, Tarantino P, Morganti S, Lynce F, Trapani D, Mayer EL, Garrido-Castro AC, Waks A, Tolaney SM. Schlam I, et al. Among authors: trapani d. Drugs. 2022 Sep;82(14):1437-1451. doi: 10.1007/s40265-022-01781-5. Epub 2022 Oct 7. Drugs. 2022. PMID: 36207645 Review.
Neoadjuvant therapy in hormone Receptor-Positive/HER2-Negative breast cancer.
Cantini L, Trapani D, Guidi L, Boscolo Bielo L, Scafetta R, Koziej M, Vidal L, Saini KS, Curigliano G. Cantini L, et al. Among authors: trapani d. Cancer Treat Rev. 2024 Feb;123:102669. doi: 10.1016/j.ctrv.2023.102669. Epub 2023 Dec 10. Cancer Treat Rev. 2024. PMID: 38141462 Review.
Treatment optimization in early triple negative breast cancer.
Kotteas E, Bielo LB, Valenza C, Santoro C, Koukoutzeli C, Trapani D, Curigliano G. Kotteas E, et al. Among authors: trapani d. Expert Rev Anticancer Ther. 2023 Jul-Dec;23(10):1107-1116. doi: 10.1080/14737140.2023.2268840. Epub 2023 Oct 26. Expert Rev Anticancer Ther. 2023. PMID: 37873652 Review.
141 results